A media report said that the US Center for Medicare and Medicaid released a preliminary list of 101 generic drugs.

Lupin share price fell after the United States Food and Drug Administration (USFDA) issued 3 observations for its Pithampur ...

Lupin share price slipped in trade after the company announced that United States Food and Drug Administration (USFDA) has ...

Mumbai: Lupin has announced that the US Food and Drug Administration (U.S. FDA) has completed a Pre-Approval Inspection with ...

Mumbai: Global pharma major Lupin Limited has announced that it has signed a distribution agreement with Scope Ophthalmics ...

Usage of generic medicines has been increased as they became boon to the poor and middle-class people because they are ...

Axis Securities has recommended seven midcap and smallcap stocks to buy in October and expects an upside potential of up to ...

Once approved by Health Canada, Adzenys and Cotempla will be the only orally disintegrating, extended-release tablets for the treatment of ADHD commercialized in Canada DENVER, CO / ACCESSWIRE / ...

Lupin to distribute Scope Ophthalmics’ Optase range of products in Mexico: Our Bureau, Mumbai Monday, September 30, 2024, 17:50 Hrs [IST] Global pharma major Lupin Limited (Lupi ...

This acquisition will enable Lupin gain access to MNI’s wide portfolio of nine brands, that are marketed as branded products in the South African retail sector, the company stated.

Lupin Ltd.'s South African subsidiary acquires nine brands from MNI, expanding its portfolio in the healthcare sector.

Once approved by Health Canada, Adzenys and Cotempla will be the only orally disintegrating, extended-release tablets for the treatment of ADHD commercialized in Canada DENVER, CO / ACCESSWIRE / ...